Vitamin C linked to fewer deaths in blood disorder trial
Vitamin C may do more than support the immune system. In a phase 2 trial of people with precancerous or low risk blood cancers, daily vitamin C did not slow abnormal cell growth, but it was linked to favorable changes in inflammation and fewer serious complications. An explorator
Vitamin C may do more than support the immune system. In a phase 2 trial of people with precancerous or low risk blood cancers, daily vitamin C did not slow abnormal cell growth, but it was linked to favorable changes in inflammation and fewer serious complications. An explorator This story matters for Health & Wellness readers tracking prescription. Reported by sciencedaily.com. Read the full original at the source link below.
Originally reported by sciencedaily.com. PrescriptionNews curates and briefs the health & wellness stories that matter. Our editorial policy →